BMY - Bristol-Myers Squibb Company - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BMY is currently covered by 18 analysts with an average price target of $54.76. This is a potential upside of $11.45 (26.44%) from yesterday's end of day stock price of $43.31.

Bristol-Myers Squibb Company's activity chart (see below) currently has 200 price targets and 201 ratings on display. The stock rating distribution of BMY is 25% BUY, 62.5% HOLD and 12.5% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.23% with an average time for these price targets to be met of 669.77 days.

Highest price target for BMY is $73, Lowest price target is $34, average price target is $58.87.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 10-Jul-2025. First documented stock forecast 22-May-2013.

Best performing analysts who are covering BMY - Bristol-Myers Squibb Company:

Chris Schott Jeffrey Holford Jami Rubin Seamus Fernandez Marc Goodman Justin Smith Andrew Baum David Risinger Vamil Divan Tim Anderson

Currently out of the existing stock ratings of BMY, 14 are a BUY (25%), 35 are a HOLD (62.5%), 7 are a SELL (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Terence Flynn (MORGAN STANLEY)

Sell

$34

$-14.43 (-29.80%)

$39

22 days ago
(10-Jul-2025)

10/13 (76.92%)

$-14.52 (-29.93%)

137

Please subscribe to see the analyst performance score

Akash Tewari (JEFFERIES)

Buy

$68

$19.57 (40.41%)

3 months 9 days ago
(23-Apr-2025)

2/3 (66.67%)

$19.47 (40.12%)

Please subscribe to see the analyst performance score

Justin Smith (SOCGEN)

Buy

3 months 10 days ago
(22-Apr-2025)

3/4 (75%)

$20.88 (37.88%)

652

Please subscribe to see the analyst performance score

Trung Huynh (UBS)

Hold

$54

$5.57 (11.50%)

$43

3 months 21 days ago
(11-Apr-2025)

1/4 (25%)

$3.29 (6.49%)

Please subscribe to see the analyst performance score

Mohit Bansal (WELLS FARGO)

Hold

$62

$13.57 (28.02%)

$52

5 months 25 days ago
(07-Feb-2025)

6/8 (75%)

$5.15 (9.06%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is BMY (Bristol-Myers Squibb Company) average time for price targets to be met?

On average it took 669.77 days on average for the stock forecasts to be realized with a an average price target met ratio 67.23

Which analyst has the current highest performing score on BMY (Bristol-Myers Squibb Company) with a proven track record?

CHRIS SCHOTT

Which analyst has the most public recommendations on BMY (Bristol-Myers Squibb Company)?

Chris Schott works at JPMORGAN and has 3 price targets and 2 ratings on BMY

Which analyst is the currently most bullish on BMY (Bristol-Myers Squibb Company)?

Chris Schott with highest potential upside - $31.57

Which analyst is the currently most reserved on BMY (Bristol-Myers Squibb Company)?

Terence Flynn with lowest potential downside - -$14.43

Bristol-Myers Squibb Company in the News

Bristol-Myers Squibb shares snap six-session losing streak

[Bristol Myers Squibb building in San Diego, CA, USA.] JHVEPhoto/iStock Editorial via Getty Images Pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY [https://seekingalpha.com/symbol/BMY]) shares inched up on Friday after six consecutive sessions of fall. The stock was up 2.1% at $44.20. BMY’s shares lost nearly 11.6% in the preceding six sessions. On a year-to-date basis, they have lost...

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we’ll look at ROE to gain a better understanding of Bristol-Myers Squibb Company (NYSE:BMY). Return on equity or ROE...